Sanofi SA has won U.S. approval for its multiple sclerosis pill Aubagio. The drug has been shown to be less effective than some rivals but has milder side effects and analysts say it could find favor among newly diagnosed patients
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment